Source: Virtual Congress 2021 – Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Savale (Le Kremlin-Bicêtre, France). Portopulmonary hypertension. Virtual Congress 2021 – Pulmonary vascular diseases

Member's Comments

No comment yet.

Related content which might interest you: Portopulmonary hypertension Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129 Year: 2005 An autopsy case of portopulmonary hypertension associated with idiopathic portal hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview Source: Eur Respir Rev 2012 21:223-233 Year: 2012 How should we treat portopulmonary hypertension? Source: Eur Respir J 2006; 28: 466-467 Year: 2006 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Iloprost treatment in portopulmonary hypertension Source: Annual Congress 2008 - Pulmonary hypertension I Year: 2008 When is pulmonary hypertension not pulmonary hypertension? Source: Eur Respir J 2001; 18: Suppl. 33, 522s Year: 2001 Pulmonary hypertension and obesity Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Sarcoidosis associated pulmonary hypertension (SAPH) in the Netherlands Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension Source: Eur Respir J 2007; 29: 220-221 Year: 2007 Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children Source: Eur Respir J 2011; 37: 70-77 Year: 2011 Sildenafil treatment for portopulmonary hypertension Source: Eur Respir J 2006; 28: 563-567 Year: 2006 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 Experience with inhaled iloprost and bosentan in portopulmonary hypertension Source: Eur Respir J 2007; 30: 1096-1102 Year: 2007 Pulmonary hypertension in children Source: Eur Respir Mon 2012; 57: 94-107 Year: 2012 Pulmonary hypertension Source: Course 2015 - Clinical exercise testing Year: 2015 Pulmonary hypertension Source: Eur Respir Rev 2015; 25: 4-11 Year: 2016